| Miss Samantha Torch, LMSW | |
|
10470 Queens Blvd Ste 200, Forest Hills, NY 11375-3694 | |
| (718) 275-6010 | |
| Not Available |
| Full Name | Miss Samantha Torch |
|---|---|
| Gender | Female |
| Speciality | Social Worker - Clinical |
| Location | 10470 Queens Blvd Ste 200, Forest Hills, New York |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1013196179 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1041C0700X | Social Worker - Clinical | 075533-1 (New York) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Miss Samantha Torch, LMSW 458 Clinton Ave, Apt. 2, Brooklyn, NY 11238-1602 Ph: () - | Miss Samantha Torch, LMSW 10470 Queens Blvd Ste 200, Forest Hills, NY 11375-3694 Ph: (718) 275-6010 |
News Archive
The Humanitarian Centre's latest Cambridge International Development report, titled "Partnerships for global health: pathways to progress," "provides insights from global health leaders on why partnerships provide a good structure for reciprocal 'teaching and learning'" and "highlights examples of innovative partnerships - particularly those where the traditional 'recipient' of development aid has taken the leading role in providing ideas and ingenuity for global health," the PLoS "Speaking of Medicine" blog reports.
BioSphere Medical, Inc. – the pioneer in the use of bioengineered microspheres to treat uterine fibroids, hypervascularized tumors and vascular malformations by a minimally invasive, image-guided medical procedure called embolotherapy – reports the publication of a study in the October 2009 issue of the Journal of Vascular Interventional Radiology in which the authors conclude that uterine artery embolization (UAE) compares favorably to laparoscopic occlusion of uterine arteries in the treatment of uterine leiomyomas (fibroids) in cases where hysterectomy or myomectomy are not options.
AgonOx today announced that it has entered into an exclusive global partnership with MedImmune, the global biologics arm of AstraZeneca, to develop agonists using its OX40 platform. MedImmune will lead further preclinical and clinical studies of this tumor-specific T-cell immunity stimulator for the potential treatment of cancer.
Around three-quarters of children diagnosed with leukaemia today will be cured of their disease, according to research published in the British Journal of Cancer today (Wednesday).
› Verified 4 days ago
Typhani Carter, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 10420 Queens Blvd, 17w, Forest Hills, NY 11375 Phone: 347-249-8961 | |
Ms. Stella Mizrakhi, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 11045 Queens Blvd Apt 314, Forest Hills, NY 11375 Phone: 347-439-4105 | |
Akiva Perlman, LCSW Clinical Social Worker Medicare: Medicare Enrolled Practice Location: 6960 108th St, Forest Hills, NY 11375 Phone: 347-342-8073 | |
Ms. Nancy Pascal, MSWI Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 10470 Queens Blvd, Floor 2, Forest Hills, NY 11375 Phone: 718-275-6010 | |
Darian Gier, LCSW Clinical Social Worker Medicare: Accepting Medicare Assignments Practice Location: 10470 Queens Blvd Ste 200, Forest Hills, NY 11375 Phone: 718-275-6010 | |
Dr. Yvette Mardis, PH.D., LCSW Clinical Social Worker Medicare: Medicare Enrolled Practice Location: 11021 73rd Rd, Suite 1j, Forest Hills, NY 11375 Phone: 718-699-8838 Fax: 718-699-8838 |